Collegium Pharmaceutical Stock In The News
| COLL Stock | USD 34.77 0.68 1.92% |
The tone or emotional content of news articles related to Collegium Pharmaceutical can affect its prices. Positive news sentiment can lead to an increase in demand for Collegium Pharmaceutical's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Collegium Pharmaceutical's news coverage and content from conventional and social sources shows investors' bearish mood towards Collegium Pharmaceutical. The specific impact of Collegium Pharmaceutical news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Collegium Pharmaceutical's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Collegium Pharmaceutical headlines in addition to utilizing other, more conventional financial analysis modules. Check out Collegium Pharmaceutical Backtesting and Collegium Pharmaceutical Hype Analysis. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.
Collegium |
Collegium Pharmaceutical Today Top News and Investor Outlook
Collegium Pharmaceutical Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Collegium and other traded companies coverage. We help investors stay connected with Collegium headlines for the 19th of April to make an informed investment decision based on correlating the impacts of news items on Collegium Stock performance. Please note that trading solely based on the Collegium Pharmaceutical hype is not for everyone as timely availability and quick action are needed to avoid losses.Collegium Pharmaceutical stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Collegium earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Collegium Pharmaceutical that are available to investors today. That information is available publicly through Collegium media outlets and privately through word of mouth or via Collegium internal channels. However, regardless of the origin, that massive amount of Collegium data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Collegium Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Collegium Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Collegium Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Collegium Pharmaceutical alpha.
Collegium Largest EPS Surprises
Earnings surprises can significantly impact Collegium Pharmaceutical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-02-27 | 2019-12-31 | -0.09 | -0.07 | 0.02 | 22 | ||
2019-08-07 | 2019-06-30 | -0.17 | -0.14 | 0.03 | 17 | ||
2023-08-03 | 2023-06-30 | 0.29 | 0.34 | 0.05 | 17 | ||
2019-05-08 | 2019-03-31 | -0.24 | -0.29 | -0.05 | 20 | ||
2015-08-12 | 2015-06-30 | -0.29 | -0.34 | -0.05 | 17 | ||
2019-11-06 | 2019-09-30 | -0.12 | -0.18 | -0.06 | 50 |
Collegium Pharmaceutical Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Collegium Pharmaceutical Stock. The global stock market is bearish. About 66% of major world exchanges and indexes are down. See today's market update for more information.
17th of April 2024
Is Collegium Pharmaceutical, Inc.s ROE Of 25 percent Impressive at finance.yahoo.com
12th of April 2024
Short Seller Behind Globe Lifes Record Drop Has Winning Record at finance.yahoo.com
11th of April 2024
Collegium Pharmaceutical to redeem outstanding 2.625 percent convertible senior notes due ... at seekingalpha.com
3rd of April 2024
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference at finance.yahoo.com
1st of April 2024
Collegium Pharmaceutical Earnings Expected to Grow Should You Buy - Yahoo Movies UK at news.google.com
27th of March 2024
Collegium Pharmaceutical shareholder returns have been stellar, earning 154 percent in 5 y... at simplywall.st
19th of March 2024
Graham Capital Management L.P. Boosts Stake in Collegium Pharmaceutical, Inc. - Defense Wo... at news.google.com
18th of March 2024
Strength Seen in Aquestive Therapeutics Can Its 16.0 percent Jump Turn into More Strength at zacks.com
13th of March 2024
3 Reasons Why Collegium Pharmaceutical Is a Great Growth Stock at zacks.com
29th of February 2024
Insider Sell EVP Chief Commercial Officer Scott Dreyer Sells 10,000 Shares of Collegium ..... at finance.yahoo.com
21st of February 2024
Collegium Pharmaceutical Q4 2023 Earnings Preview at seekingalpha.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Collegium Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Collegium Pharmaceutical's short interest history, or implied volatility extrapolated from Collegium Pharmaceutical options trading.
Check out Collegium Pharmaceutical Backtesting and Collegium Pharmaceutical Hype Analysis. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Collegium Stock analysis
When running Collegium Pharmaceutical's price analysis, check to measure Collegium Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Collegium Pharmaceutical is operating at the current time. Most of Collegium Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Collegium Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Collegium Pharmaceutical's price. Additionally, you may evaluate how the addition of Collegium Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Collegium Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 51.976 | Earnings Share 1.29 | Revenue Per Share 16.797 | Quarterly Revenue Growth 0.155 | Return On Assets 0.1028 |
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.